Harrow, Inc.

NasdaqGM:HROW Stock Report

Market Cap: US$1.8b

Harrow Future Growth

Future criteria checks 5/6

Harrow is forecast to grow earnings and revenue by 78.4% and 33.2% per annum respectively while EPS is expected to grow by 79.4% per annum.

Key information

78.4%

Earnings growth rate

79.4%

EPS growth rate

Pharmaceuticals earnings growth23.6%
Revenue growth rate33.2%
Future return on equityn/a
Analyst coverage

Low

Last updated04 Oct 2024

Recent future growth updates

Recent updates

Harrow's Focus - Reviving Old Drugs In A Crowded Market

Oct 02

Harrow: 3 Business Models, One Mission

Sep 10

Borrowing Cash To Burn It: The Curious Case Of Harrow

Aug 21

Harrow: The Bull Thesis Is On Track, But Short-Term Challenges Loom

May 02

Harrow's Drug Iheezo Is Off To A Great Start

Feb 19

Harrow: Temporary Disruption In Stock Price Creates Excellent Opportunity

Jan 30

Harrow sells non‑ophthalmic compounding business, terms undisclosed

Oct 05

Harrow Health soars ~27% on FDA nod of anesthesia gel for the surface of the eye

Sep 27

SRK Capital - Harrow Health: Market Missing The Forest For The Trees

Aug 19

These 4 Measures Indicate That Harrow Health (NASDAQ:HROW) Is Using Debt Extensively

Aug 11
These 4 Measures Indicate That Harrow Health (NASDAQ:HROW) Is Using Debt Extensively

Buy Deep Moated, Fast Growing, Superbly Managed Harrow Health Ahead Of New Product Launch

May 23

Does Harrow Health (NASDAQ:HROW) Have A Healthy Balance Sheet?

May 12
Does Harrow Health (NASDAQ:HROW) Have A Healthy Balance Sheet?

Is Harrow Health (NASDAQ:HROW) A Risky Investment?

Dec 15
Is Harrow Health (NASDAQ:HROW) A Risky Investment?

Does Harrow Health (NASDAQ:HROW) Have A Healthy Balance Sheet?

Aug 24
Does Harrow Health (NASDAQ:HROW) Have A Healthy Balance Sheet?

Harrow Health prices 8.625% senior notes due 2026

Jun 15

Harrow Health: An 8.3% Baby Bond Yield With Low Balance Sheet Leverage

May 28

Earnings and Revenue Growth Forecasts

NasdaqGM:HROW - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202639998N/A442
12/31/20252813138464
12/31/2024199-171194
6/30/2024154-34-210N/A
3/31/2024139-31-147N/A
12/31/2023130-24-1494N/A
9/30/2023114-14-167-9N/A
6/30/2023103-16-147-8N/A
3/31/202393-18-146-7N/A
12/31/202289-14-62N/A
9/30/202288-23-124N/A
6/30/202284-24-132N/A
3/31/202279-21-133N/A
12/31/202172-18-115N/A
9/30/202167-1046N/A
6/30/2021637911N/A
3/31/2021521023N/A
12/31/202049-3-2-1N/A
9/30/202047-2-11N/A
6/30/202045-22-3-2N/A
3/31/202051-2402N/A
12/31/2019510-11N/A
9/30/20195016-2-1N/A
6/30/20194825-30N/A
3/31/20194529-20N/A
12/31/20184115-21N/A
9/30/201837-6-10N/A
6/30/201833-9-3-2N/A
3/31/201830-10N/A-6N/A
12/31/201727-12N/A-9N/A
9/30/201725-15N/A-11N/A
6/30/201724-13N/A-12N/A
3/31/201722-20N/A-13N/A
12/31/201620-19N/A-11N/A
9/30/201618-18N/A-12N/A
6/30/201615-18N/A-11N/A
3/31/201613-17N/A-11N/A
12/31/201510-16N/A-11N/A
9/30/20157-14N/A-10N/A
6/30/20155-12N/A-9N/A
3/31/20153-11N/A-8N/A
12/31/20142-10N/A-7N/A
9/30/20141-9N/A-6N/A
6/30/20141-9N/A-6N/A
3/31/20140-9N/A-5N/A
12/31/20130-8N/A-4N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: HROW is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.5%).

Earnings vs Market: HROW is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: HROW is expected to become profitable in the next 3 years.

Revenue vs Market: HROW's revenue (33.2% per year) is forecast to grow faster than the US market (8.8% per year).

High Growth Revenue: HROW's revenue (33.2% per year) is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if HROW's Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y